Social anxiety disorder clinical course and outcome: Review of Harvard/Brown Anxiety Research Project (HARP) findings

Journal of Clinical Psychiatry

Volumn 67, Issue SUPPL. 12, 2006, Pages 14-19

  Keller, Martin B ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGORAPHOBIA; BEHAVIOR THERAPY; CHRONIC DISEASE; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; CONVALESCENCE; DEPRESSION; DIAGNOSTIC TEST; DISEASE COURSE; DRUG USE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HUMAN; LONG TERM CARE; LONGITUDINAL STUDY; OUTCOME ASSESSMENT; PANIC; PERSONALITY DISORDER; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; REMISSION; REVIEW; SOCIAL INTERACTION; SOCIAL PHOBIA;

ADULT; CHRONIC DISEASE; COMORBIDITY; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PERSONALITY DISORDERS; PHOBIC DISORDERS; PREVALENCE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; RECURRENCE; TREATMENT OUTCOME;

EID: 33751549949     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Dyck IR, Phillips KA, Warshaw MG, et al. Patterns of personality pathology in patients with generalized anxiety disorder, panic disorder with and without agoraphobia, and social phobia. J Personal Disord 2001;15:60-71
2. Massion AO, Warshaw MG, Keller MB. Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. Am J Psychiatry 1993;150:600-607
3. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989;262:914-919
4. Keller MB. Course and outcome of GAD, panic disorder with and without agoraphobia, and social phobia. Presented at the Second Annual Psychiatric Annals Symposium, March 26, 2004; New York, NY
5. Keller MB, Lavori PW, Friedman B, et al. The longitudinal interval follow-up evaluations: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987;44:540-548
6. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 1978;35:773-782
7. Vasile RG, Bruce SE, Goisman RM, et al. Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia. Depress Anxiety 2005;22:59-67
8. Davidson JR, Potts N, Richichi E, et al. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993;13:423-428
9. Versiani M. A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia). World J Biol Psychiatry 2000;1:27-33